Vir Biotechnology
Earnings Surprise
Analysts estimated VIR earnings of $-0.50 per share this quarter (Q4). VIR's actual earnings were $-0.31 per share.
VIR EPS surprise of 37.56%Analysts estimated VIR earnings of $-0.86 per share this quarter (Q3). VIR's actual earnings were $-1.17 per share.
VIR EPS surprise of -35.70%Analysts estimated VIR earnings of $-0.73 per share this quarter (Q2). VIR's actual earnings were $-0.80 per share.
VIR EPS surprise of -9.48%Analysts estimated VIR earnings of $-0.88 per share this quarter (Q4). VIR's actual earnings were $-0.76 per share.
VIR EPS surprise of 13.75%Analysts estimated VIR earnings of $-1.06 per share this quarter (Q3). VIR's actual earnings were $-1.56 per share.
VIR EPS surprise of -46.71%Analysts estimated VIR earnings of $-0.90 per share this quarter (Q2). VIR's actual earnings were $-1.02 per share.
VIR EPS surprise of -12.81%Analysts estimated VIR earnings of $-1.06 per share this quarter (Q1). VIR's actual earnings were $-0.48 per share.
VIR EPS surprise of 54.80%Analysts estimated VIR earnings of $-1.02 per share this quarter (Q4). VIR's actual earnings were $-0.86 per share.
VIR EPS surprise of -15.51%